Fresh analysis suggests that individuals who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who halt conventional lifestyle regimens.
Published data in a prominent medical journal shows that while overweight individuals can lose a large proportion of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month after stopping.
"Individuals buying such treatments should be informed of the danger of rapid weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
This pace of regain implies a reversion to starting mass in about one and a half years.
Comparing Therapies
The analysis, which looked at dozens of studies involving thousands of patients, compared the outcomes of the injectable medications with older methods.
The team emphasize that individuals who lose weight through diet and exercise typically see a less rapid weight regain—approximately 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Experts suggest the mode of action of the drugs explains the heightened regain.
These medications imitate a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making overeating far more likely."
An Ongoing Issue?
Health authorities recommend the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals contend that, due to the likelihood of weight regain, the treatment is often long-term.
This view is supported by drug manufacturers, who note that the results "emphasize the chronic character of obesity," comparing it to managing conditions like diabetes.
Patient Experiences
Users who have come off the jabs explain a intense resurgence of appetite.
"I experienced a switch that goes on and I was suddenly starving," recalled one woman.
This difficulty is exacerbated if users have not developed sustainable lifestyle or habit modifications during therapy.
Growing Interest
Survey data show that a significant number of adults in the UK have used these injections in the past year, with interest being substantial.
- Adoption is greater among women than men.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
Ultimately, experts stress that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent fix and long-term success likely depends on ongoing behavioural management.